Suzushima H, Matsushita S, Nakamura R, Nishimura R, Okubo T, Asou N, Kawa-Ha K, Hirai K, Takatsuki K. Detection of Epstein-Barr Viral DNA in aggressive CD8+ T cell Leukemic Cells. Br J Haematol 1992; 82: 774-776.
Ryotaro Nakamura, Erkut Bahceci, Elizabeth J. Read, Susan F. Leitman, Charles S. Carter, Richard Childs, Cynthia E. Dunbar, Neal S. Young, Ronald Gress, Rosemary Altemus, and A. John Barrett. Transplant dose of CD34+ and CD3+ cells predicts outcome in patients with haematological malignancies undergoing T-cell depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back. Br J Haematol 2001; 115: 95-104
Diane E. Epperson, Ryotaro Nakamura, Yogen Saunthararajah, A. John Barrett Oligoclonal T cell expansion in myelodysplastic syndrome: Evidence for an autoimmune process. Leuk Res 2001; 25: 1075-1083.
Maciejewski JP, Follmann D, Nakamura R, Saunthararajah Y, Rivera CE, Simonis T, Brown KE, Barrett JA, Young NS. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood 2001; 98: 3513-3519 (plenary paper).
Nancy Hensel, J Jos Melenhorst, Kenneth Bradstock, Anthony Schwarer, Rhoda Eniafe, Ryotaro Nakamura, A. John Barrett. Flow cytometric quantification and characterization of the T-lymphocyte memory response to cytomegalovirus in healthy donors. Cytotherapy 2002; 4: 29-40.
Hoon Kook, Antonio M. Risitano, Weihua Zeng, Marcin Wlodarski, Craig Lottemann, Ryotaro Nakamura, John Barrett, Neal S. Young and Jaroslaw P. Maciejewski. Changes in T-cell receptor VB-repertoire in aplastic anemia: Effects of different immunosuppressive regimens. Blood 2002; 99: 3668-3675
Jeffrey Molldrem, Mary Rivera, Erkut Bahceci, Cynthia Dunbar, Johnson2 Liu, Yogen Saunthararajah, Ryotaro Nakamura, Neal S. Young, and John Barrett. Treatment of the bone marrow failure of myelodysplastic syndrome with antithymocyte globulin. Annals of Internal Medicine 2002 137: 156-163.
Yogen Saunthararajah*, Ryotaro Nakamura*, Jun-mo Nam, Jamie Robyn, Loberiza Fausto, Jeffrey Molldrem, Toni Simones, Neal S. Young, A. John Barrett. HLA-15 (DR2) is over-represented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood 2002; 100: 1570-1574. *These authors contributed equally to the work.
Magnus K. Magnusson, Kristin E. Meade, Ryotaro Nakamura, John Barrett, and Cynthia E. Dunbar. STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta-receptor fusion oncogene. Blood 2002; 100: 1088-1091.
Ryotaro Nakamura, Karol Cortez, Scott Solomon, Minoo Battiwalla, Vee J. Gill, Nancy Hensel, John E. Bennett, Richard Childs, A. John Barrett. High-dose acyclovir and preemptive gancyclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 235-42.
J. Joseph Melenhorst, Rhoda Eniafe, Dean Follmann, Ryo Nakamura, Martha Kirby, A. John Barrett. Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndrome. Br J Haematol 2002; 119: 97–105.
Elaine Sloand, Sonnie Kim, Atanu Basu, Ryotaro Nakamura, Jaroslow P. Maciejewski, Antonio Risitano, A. John Barrett, Neal S. Young. Fas-mediated appoptosis is important in regulating cell replication and death in hematopoietic cells with trisomy 8 but not in cells with other chromosomal abnormalities. Blood 2002; 100: 4427-4432.
Huhn RD, Fogarty P, Nakamura R, Reed EJ, Rick M, Leitman SF, Greene A, Gratwohl A, Young NS, Barrett AJ, Dunbar CE. High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of chronic refractory autoimmune thrombocytopenia. Blood 2003; 101: 71-77.
Scott Solomon, Ryotaro Nakamura, Elizabeth J. Read, Susan F. Leitman, Charles S. Carter, Richard Childs, Cynthia E. Dunbar, Neal S. Young, A. John Barrett. Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation. Bone Marrow Transplant 2003; 31:783-8.
Hiroshi Fujiwara, Giuseppe Sconocchia, Jos Melenhorst, Rhoda Eniafe, Ryotaro Nakamura, Nancy Hensel and A John Barrett. Tissue-restricted T cell alloresponses across HLA barriers: Selection and identification of leukemia-restricted CTL in HLA mismatched stimulator-responder pairs. Bone Marrow Transplant. 2003;32:371-8.
Yogen Saunthararajah, Ryotaro Nakamura, Robert Wesley, A. John Barrett Predicting a Response to Immunosuppression in Patients with Myelodysplastic Syndrome. Blood. 2003 Oct 15;102(8):3025-7 *These authors contributed equally to the work.
Battiwalla M, Melenhorst J, Saunthararajah Y, Nakamura R, Molldrem J, Young NS, Barrett AJ. HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders. Br J Haematol. 2003; 123:449-453.
Ryotaro Nakamura, Minoo Battiwalla, Scott Solomon, Dean Follmann, Sakti Chakrabarti, Karoll Cortez, Nancy Hensel, Richard Childs, A. John Barrett. Persisting CMV antigenemia predicts for increased relapse and treatment failure in T cell-depleted stem cell transplants. Biol Blood and Marrow Transplant 2004; 10: 49-57.
Francisco Lopez, Pablo Parker, Auayporn Nademanee, Roberto Rodriguez, David Snyder, Ravi Bhatia, Warren Chow, Sandra Cohen, Peter Falk, Henry Fung, Amrita Krishnan, Neil Kogut, Kim Margolin, Arturo Molina, Ryotaro Nakamura, Margaret O’Donnell, Leslie Popplewell, Joseph Rosenthal, Firoozeh Sahebi, Eileen Smith, George Somlo, Ricardo Spielberger, Anthony Stein, Robert Sweetman, Jasmin Zain and Stephen Forman.Efficacy of Mycophenolate Mofetil (MMF) in the Treatment of Chronic Graft Versus Host Disease, Biol Blood and Marrow Transplant 2005; 11: 307-313.
Auayporn Nademanee, Stephen Forman, Arturo Molina, Henry Fung, David Smith, Andrew Dagis, Cheuk Kwok, Dave Yamauchi, Anne-Line Anderson, Peter Falk, Amrita Krishnan, Mark Kirschbaum, Neil Kogut, Ryotaro Nakamura, Margaret O'Donnell, Pablo Parker, Leslie Popplewell, Vinod Pullarkat, Roberto Rodriguez, Firoozeh Sahebi, Eileen Smith, David Snyder, Anthony Stein, Ricardo Spielberger, Jasmine Zain, Christine White, and Andrew Raubitschek. A Phase I/II Trial of High-Dose Yttrium 90 ibritumomab tiuxetan in Combination with High-Dose Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Patients with Poor-Risk or Relapsed Non-Hodgkins Lymphoma (NHL). Blood 2005;106:2896-2902.
Ryotaro Nakamura, Sakti Chakrabarti, Cem Akin, Jamie Robyn, Erkut Bahceci, Adeira Greene, Richard Childs, Cynthia E. Dunbar, Dean D. Metcalfe, and A John Barrett. A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis. Bone Marrow Transplant. 2006; 37: 353-8.
Firoozeh Sahebi, Stephen Forman, Neil M. Kogut,* Peter M. Falk, Ricardo Spielberger, Pablo Parker, Amrita Krishnan, Robert Rodriguez, Ryotaro Nakamura, Auayporn Nademanee, Leslie Popplewell, Henry Fung, Paul Frankel, Robert Tin, Penka Ilieva, George Somlo. Maintenance Thalidomide Following Single Cycle Autologous Peripheral Blood Stem Cell Transplant in Patients with Multiple Myeloma. Bone Marrow Transplant. 2006; 37: 825-9.
Pullarkat V, Bedell V, Kim Y, Bhatia R, Nakamura R, Forman S, Sun J, Senitzer D, Slovak ML. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone. Leuk Res. 2006 Jul 27; [Epub ahead of print]
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 03/07.
